未登录

N

Nikolai Zhelev

university of abertay dundee

H指数:19

被引数:1,704

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

What is the potential of p53 isoforms as a predictive biomarker in the treatment of cancer?

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

IF3.6

2019-01-0717

OAAI

The role of lipid phase of erythrocyte membranes in ensuring haemoglobin's oxygen-binding capacity during experimental hyperoxia

JOURNAL OF BIOTECHNOLOGY

IF3.9

2018-08-010

PREAI

Physical and Chemical Processes and the Morphofunctional Characteristics of Human Erythrocytes in Hyperglycaemia

FRONTIERS IN PHYSIOLOGY

IF3.4

2017-08-307

OAAI

Novel HPLC-based assay for measuring thymidine kinase activity as a cancer biomarker

JOURNAL OF BIOTECHNOLOGY

IF3.9

2017-08-010

PREAI

Next-generation technologies to develop new therapeutics in oncology and cardiology

JOURNAL OF BIOTECHNOLOGY

IF3.9

2016-08-010

PREAI

Study of the effect of novel CDK9 inhibitor on in vitro-induced hypertrophy in human stem-cells-derived cardiomyocytes

JOURNAL OF BIOTECHNOLOGY

IF3.9

2016-08-010

PREAI

Validation of a novel assay for cardiology drug screening using hESC-derived cardiomyocyte spheroids - Mini-hearts

JOURNAL OF BIOTECHNOLOGY

IF3.9

2016-08-011

PREAI

Discovery and development of Seliciclib. How systems biology approaches can lead to better drug performance

Seliciclib的发现和发展。系统生物学方法如何导致更好的药物性能

JOURNAL OF BIOTECHNOLOGY

IF3.9

2015-05-0153

OAAI

Discovery and development of Seliciclib. How systems biology approaches can lead to better drug performance

JOURNAL OF BIOTECHNOLOGY

IF3.9

2014-09-010

OAAI

Process-based vs. data-driven modelling of cancer cell behaviour

JOURNAL OF BIOTECHNOLOGY

IF3.9

2014-09-010

PREAI

Effect of roscovitine on cardiac hypertrophy in human stem cell derived cardiomyocytes

CURRENT OPINION IN BIOTECHNOLOGY

IF7

2013-07-011

PREAI

In sickness and in health: a set of markers for individual repair capacity in risk assessment, monitoring and prognosis of human disease

CURRENT OPINION IN BIOTECHNOLOGY

IF7

2013-07-012

PREAI

Recent advances in the development of cyclin-dependent kinase inhibitors as new therapeutics in oncology and cardiology

CURRENT OPINION IN BIOTECHNOLOGY

IF7

2013-07-011

PREAI

A quantitative integrated systems biology approach for modeling cell cycle pathways in normal and tumor cells

CANCER RESEARCH

IF16.6

2012-04-010

PRE

Differences in the DDR enzymes activation kinetics between normal and cancer cells could be utilized to achieve targeted cellular sensitivity towards genotoxic agents

CANCER RESEARCH

IF16.6

2012-04-010

PRE

A new method for identifying a data-consistent self-reconfigurable predictive bio-network model of the cell cycle based on time series data and its application in cancer systems biology

CANCER RESEARCH

IF16.6

2012-04-011

PRE

A novel quantitative systems biology approach to cancer research and treatment

CURRENT OPINION IN BIOTECHNOLOGY

IF7

2011-09-014

PREAI

Cell-based nanosensors for systems biology research and drug development

CURRENT OPINION IN BIOTECHNOLOGY

IF7

2011-09-012

PREAI

Cancer research and personalised medicine: a new approach to modelling time-series data using analytical methods and Half systems

CURRENT OPINION IN BIOTECHNOLOGY

IF7

2011-09-015

PREAI

Novel insights of Ataxia Telangiectasia Mutated (ATM) regulation and its potential as a target for therapeutic intervention in cancer

CURRENT OPINION IN BIOTECHNOLOGY

IF7

2011-09-015

PREAI